Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Assay and Drug Development Technologies|March 21, 2012
An automated electrophysiological assay for differentiating Ca(v)2.2 inhibitors based on state dependence and kineticsAndrew M Swensen, Wende Niforatos, Timothy A Vortherms, et al.European Journal of Pharmacology|November 4, 2008
Cloning and characterization of the monkey histamine H3 receptor isoformsMarina I Strakhova, Gerard B Fox, Tracy L Carr, et al.Neuron|February 22, 2005
Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1Matthew S Goldberg, Antonio Pisani, Marian Haburcak, et al.Bioorganic & Medicinal Chemistry Letters|July 24, 2013
Synthesis and SAR of 4-aminocyclopentapyrrolidines as orally active N-type calcium channel inhibitors for inflammatory and neuropathic painXenia Beebe, Clinton M Yeung, Daria Darczak, et al.Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|March 12, 2011
Comparative analysis of inactivated-state block of N-type (Ca(v)2.2) calcium channelsTimothy A Vortherms, Andrew M Swensen, Wende Niforatos, et al.Free Radical Biology & Medicine|May 22, 2023
Suppression of superoxide/hydrogen peroxide production at mitochondrial site I<sub>Q</sub> decreases fat accumulation, improves glucose tolerance and normalizes fasting insulin concentration in mice fed a high-fat dietMark A Watson, Harmanmeet Brar, Edwin T Gibbs, et al.Biochemical Pharmacology|December 14, 2011
A-1048400 is a novel, orally active, state-dependent neuronal calcium channel blocker that produces dose-dependent antinociception without altering hemodynamic function in ratsVictoria E Scott, Timothy A Vortherms, Wende Niforatos, et al.The Journal of Pharmacology and Experimental Therapeutics|November 17, 2019
Biological Characterization of F508delCFTR Protein Processing by the CFTR Corrector ABBV-2222/GLPG2222Ashvani K Singh, Yihong Fan, Corina Balut, et al.Journal of Medicinal Chemistry|November 6, 2008
cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesiaHuaqing Liu, Robert J Altenbach, Tracy L Carr, et al.Journal of Medicinal Chemistry|September 25, 2008
Structure-activity studies on a series of a 2-aminopyrimidine-containing histamine H4 receptor ligandsRobert J Altenbach, Ronald M Adair, Brian M Bettencourt, et al.Pageof 3